The study, published on 29 September 2026 and conducted on behalf of the EDEMA Collaborative, addresses a deceptively simple problem. Cumulative fluid balance, often abbreviated CFB, is the running net total of every milliliter a patient receives and every milliliter the patient loses. Expressed as a percentage of body weight, percent cumulative fluid balance, or %CFB, has emerged in recent years as one of the most powerful predictors of outcomes in critically ill children. Prior meta-analyses, including a 2024 systematic review in EClinicalMedicine and a 2018 analysis in JAMA Pediatrics, have linked positive fluid balance to longer ventilation, acute kidney injury, and increased mortality. The AWARE study, a multicenter international investigation, further demonstrated that both the magnitude and the timing of fluid overload shape outcomes in children.

Despite this growing evidence base, the researchers argue that fluid overload remains chronically under-recognized in practice. Calculating %CFB by hand requires tallying dozens of inputs: intravenous medications, blood products, nutrition, insensible losses, urine output, drains, and dialysis effluent, all indexed to a weight that may itself change daily. In a busy pediatric intensive care unit, that arithmetic is rarely performed in real time, and clinicians often rely on intuition or spot checks. The new study set out to remove that barrier by embedding the calculation inside the electronic health record itself, so that the number appears automatically wherever clinicians already work.

The technical approach is notable for what it does not require. Rather than building a standalone application or a separate dashboard, the team worked with information-technology expertise, acknowledged in the paper to Denise Dauterman at NYU, to create the calculator within the EHR and then migrate it into the University of Rochester Medical Center system. The calculator indexes net fluid balance to the patient’s weight and updates continuously, presenting a real-time %CFB value drawn from the same documentation flows that clinicians already use. This design choice matters because tools that live outside the clinical workflow are notoriously abandoned, while those woven into the record itself become part of the ambient information environment of the unit.

To validate the tool, the researchers performed a retrospective cohort study in both the pediatric cardiac intensive care unit and the general medical-surgical pediatric intensive care unit of a single center. They included every hospital encounter between June and November 2025, ultimately capturing 468 unique encounters that spanned 154 calendar days and totaled 2,041 ICU patient-days. That scale is meaningful: cardiac patients and general medical-surgical patients have very different fluid landscapes, with the former often receiving large volumes of cardiopulmonary bypass-related fluid and the latter spanning everything from respiratory failure to sepsis, so a calculator that performs across both populations is more likely to generalize.

The validation logic was straightforward but demanding. For each of the first fourteen ICU days of every encounter, the team compared the real-time %CFB produced by the embedded calculator against a documented %CFB computed from de-identified retrospective data extracted from the same electronic health record. The threshold for agreement was strict: the researchers counted any day on which the two values differed by more than 0.1 percent cumulative fluid balance as a discrepancy. On 1,971 of 2,041 patient-days, or 96.6 percent, the real-time calculator matched the documented value within that narrow margin. Across the entire cohort, the correlation between the two measures exceeded 0.99, an R-squared value indicating that the embedded calculation reproduces the reference calculation almost perfectly.

The discrepancies that did arise were concentrated in a small subset of patients. Thirty-four encounters, twenty from the pediatric cardiac ICU and fourteen from the pediatric medical-surgical ICU, showed differences greater than 0.1 percent at some point during their stay. The paper does not identify a single cause for these outliers, but the pattern is familiar to anyone who has audited fluid data: complex patients accumulate documentation edge cases, from unrecorded insensible losses to medications charted in unexpected units, and the highest-acuity children generate the most intricate fluid histories. The near-perfect overall correlation suggests these are data-quality events rather than flaws in the calculator’s logic, but they define exactly where future attention should focus.

What makes the result clinically significant is the framing of reliability as evidence. The authors state plainly that they developed the real-time %CFB calculator within the EHR and validated its accuracy in an attempt to provide evidence of its reliability for clinical use. That evidentiary step is often skipped when institutions deploy internal clinical tools, leaving clinicians to trust software on faith. By quantifying agreement against a retrospective gold standard across more than two thousand patient-days, the EDEMA Collaborative has produced the kind of validation data that can support adoption at other centers, and the funding trail, a grant from the George M. O’Brien Kidney Resource Alliance, signals that the National Institutes of Health sees kidney-focused informatics as a priority area.

The broader context is a field in transition. A 2025 fluid management bundle study in Pediatric Critical Care Medicine found that structured protocols were associated with reduced excess fluid accumulation in children with respiratory failure, and a state-of-the-art review published the same year in Intensive Care Medicine Paediatric and Neonatal catalogued how fluid balance shapes outcomes across pediatric critical illness. The Pediatric Acute Disease Quality Initiative has convened experts to standardize how fluid assessment should be performed in sick children. What has been missing is infrastructure: a way to make the fluid balance number as continuously visible as a heart rate or an oxygen saturation. The new calculator is a direct answer to that gap, and its authors suggest that a %CFB calculator that indexes net fluid balance to weight and is readily available may bring greater attention to clinical fluid overload.

There are, of course, limits to what a single-center retrospective study can establish. The validation took place within one institution’s electronic health record configuration, and EHR implementations vary widely across health systems, meaning the calculator’s performance elsewhere will depend on local data practices and the fidelity of the migration. The study also measured agreement between calculations, not whether displaying the number in real time actually changes clinician behavior or improves patient outcomes, a question that will require prospective interventional trials. Still, the arithmetic is unambiguous: a tool that agrees with a rigorous reference standard on 96.6 percent of patient-days, with correlation above 0.99, has cleared the threshold of reliability that any behavioral study would demand. For the hundreds of thousands of children who pass through intensive care units each year, the study suggests that the single most important number in fluid management may soon be computed for them, continuously, before anyone has to reach for a calculator.

Subject of Research: Development and validation of an electronic health record-based cumulative fluid balance calculator for critically ill children

Article Title: Development and Validation of an Electronic Fluid Balance Calculator for Critically Ill Children

Article References: Hasson, D. C., Odum, J. D., Kothari, U., Shah, A. J., Braun, C. G., Dixon, C. G., Fitzgerald, J. C., Dziorny, A. C., & on behalf of the EDEMA Collaborative (2026). Development and Validation of an Electronic Fluid Balance Calculator for Critically Ill Children. Pediatric Research. https://doi.org/10.1038/s41390-026-05496-1

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05496-1

Keywords: pediatric intensive care, fluid balance, fluid overload, electronic health record, cumulative fluid balance, clinical calculator, validation study, pediatric research, acute kidney injury, critical care informatics, retrospective cohort, EDEMA Collaborative

Augmented renal clearance, often abbreviated ARC, describes a condition in which the kidneys filter blood at a rate well above what would be expected for a given patient. It has been recognized for more than a decade in critically ill trauma and sepsis patients, where it is usually treated as a pharmacokinetic problem: drugs that are cleared by the kidneys, particularly antibiotics, are eliminated so quickly that standard doses may fail to reach therapeutic levels in the blood. The Montreal team, led by neurosurgeon Kazunori Oda, set out to ask a different question. Rather than viewing the hyperfiltering kidney purely as a dosing challenge, they hypothesized that it might serve as a window into a broader hyperdynamic state, one that also drives the catabolic firestorm that follows severe brain injury.

The study examined intensive care unit admissions of adults with severe traumatic brain injury at a tertiary academic level I trauma center between 2015 and 2024. Because directly measured urinary creatinine clearance was not systematically available in this retrospective setting, the researchers relied on serum-creatinine-estimated creatinine clearance, calculated from routine blood work. They defined estimated augmented renal clearance, or eARC, as an estimated creatinine clearance of at least 130 milliliters per minute per 1.73 square meters of body surface area at one or more time points during the first 28 days after injury. This threshold is consistent with definitions used widely in the critical care literature, where values above 130 are generally considered supranormal.

Of the 342 admissions included in the analysis, eARC occurred in 197 patients, or 57.6 percent. That figure is striking: it means that in this population, a hyperfiltering kidney was the rule rather than the exception. The patients who developed eARC were younger, more often male, and had lower admission Glasgow Coma Scale scores, suggesting more severe impairment of consciousness at presentation. These demographic and clinical associations echo earlier work showing that young trauma patients with robust physiological reserve are the ones most likely to mount an exaggerated renal response, even as their brains bear the brunt of the injury.

The central finding of the study concerns body weight. Patients with eARC experienced a median day-28 body weight loss of 12.7 percent, compared with essentially no change, 0.0 percent, in patients without eARC, a difference that was highly statistically significant. Severe weight loss was also markedly more frequent in the eARC group. To put the magnitude in perspective, a double-digit percentage loss of body mass within a month is far beyond what would be expected from simple fluid shifts or reduced appetite; it points to substantial depletion of lean tissue and fat stores, the kind of catabolic erosion that has been associated with worse outcomes in critically ill and neurotrauma populations.

To make sure the association was not an artifact of confounding, the investigators took a rigorous approach to variable selection, guided by a directed acyclic graph, a formal framework that maps out plausible causal relationships and identifies which covariates must be adjusted for. In exploratory multivariable analysis adjusting for age and admission Glasgow Coma Scale score, eARC remained independently associated with severe day-28 weight loss. The team also ran a battery of sensitivity analyses designed to rule out alternative explanations. They incorporated calories derived from propofol, the sedative commonly infused in brain-injured patients, which is delivered in a lipid emulsion and can contribute substantial energy intake that is often overlooked in nutrition calculations.

Those sensitivity analyses proved revealing in their own right. Once propofol-derived calories were counted, total energy delivery turned out to be similar between the eARC and non-eARC groups, which weakens the argument that the weight loss simply reflected underfeeding. Likewise, serum sodium concentrations, total fluid input, urine output, and the input-minus-urine fluid balance estimate did not show clear group-level differences that could account for the observed weight-loss gap. In other words, the excess weight loss in eARC patients could not be readily explained by either a caloric deficit or by large-scale fluid and electrolyte shifts, leaving a primary metabolic or catabolic mechanism as the leading candidate.

The biological plausibility of such a mechanism is supported by a growing body of literature. Severe traumatic brain injury is known to trigger one of the most intense hypermetabolic states in medicine, with resting energy expenditure and nitrogen excretion rising sharply in the first weeks after injury. Previous observational work has linked augmented renal clearance to increased muscle catabolism and urinary nitrogen loss in trauma patients, and studies of atrial natriuretic peptide and cardiac output in brain-injured patients have suggested that the hyperdynamic circulation driving renal hyperfiltration may be part of a systemic stress response. Creatinine itself is generated from muscle, so a rapidly falling serum creatinine in a catabolic patient can inflate clearance estimates while simultaneously signaling loss of muscle mass, a coupling that the authors acknowledge as a limitation of relying on estimated rather than measured clearance.

The clinical implications, if confirmed, could be substantial. If eARC identifies a metabolically vulnerable subgroup of brain-injured patients, then a routine serum creatinine, a test drawn almost daily in every intensive care unit, could become an early warning flag prompting intensified nutritional surveillance, earlier dietitian involvement, closer monitoring of protein delivery, and perhaps pharmacokinetic dose adjustments for renally cleared drugs. The authors are careful to frame their findings as hypothesis generating. Because the study was retrospective and relied on estimated rather than measured creatinine clearance, and because body weight alone cannot distinguish fluid changes from true tissue loss, they call for prospective studies using directly measured creatinine clearance, detailed sodium and water balance assessment, and direct body composition measures such as bioelectrical impedance or imaging-based muscle quantification.

For now, the study adds an intriguing piece to the puzzle of why some brain injury patients waste away despite modern critical care. It suggests that the kidney, an organ rarely at the center of neurotrauma discussions, may be broadcasting a signal about systemic metabolic state that clinicians have been reading only through a pharmacokinetic lens. With more than half of severe traumatic brain injury patients in the cohort showing supranormal renal filtration, and with that subgroup losing on average nearly 13 percent of their body weight in a month, the case for watching the kidneys as metabolic sentinels has become considerably stronger. Whether aggressive, eARC-guided nutritional intervention can change the trajectory for these patients is the question that prospective research must now answer.

Subject of Research: Augmented renal clearance and metabolic weight loss after severe traumatic brain injury

Article Title: Serum-Creatinine-Estimated Augmented Renal Clearance is Associated with Marked Weight Loss after Severe Traumatic Brain Injury

Article References: Oda, K., Nedelcu, R., Abouassaly, M., Mourad, A. A., Grubb, K., Saluja, R. S., & Marcoux, J. (2026). Serum-Creatinine-Estimated Augmented Renal Clearance is Associated with Marked Weight Loss after Severe Traumatic Brain Injury. Neurocritical Care. https://doi.org/10.1007/s12028-026-02666-1

Image Credits: AI Generated

DOI: 10.1007/s12028-026-02666-1

Keywords: augmented renal clearance, traumatic brain injury, neurocritical care, creatinine clearance, weight loss, nutrition, catabolism, fluid balance, intensive care, hypermetabolism, neurotrauma, propofol

Bronchopulmonary dysplasia, or BPD, is a chronic lung disease defined clinically by the continued need for respiratory support or supplemental oxygen at 36 weeks of postmenstrual age. It affects a substantial fraction of very preterm survivors and carries lifelong consequences, including increased risks of asthma-like symptoms, rehospitalization, impaired growth, and neurodevelopmental difficulties. The disorder arises from an intricate interplay of prematurity itself, inflammation, mechanical ventilation, oxygen toxicity, infection, and disturbed fluid homeostasis. Because the preterm lung must transition from a fluid-filled fetal state to an air-filled neonatal one within minutes to days, the way water moves into and out of the body during that transition has long been suspected to matter. Excess extracellular water can flood the pulmonary interstitium, worsen compliance, prolong the need for ventilation, and thereby amplify lung injury. This biological logic underpins the standard practice of restricting fluid intake and watching for a postnatal weight loss of roughly five to fifteen percent in the first week as a sign that the infant is clearing fluid appropriately.

The new study set out to characterize the longitudinal trajectories of fluid output, fluid balance, and related indicators across the first seven days of life, and then to test how those trajectories relate to moderate-to-severe BPD, classified according to the 2018 NICHD criteria. The investigators assembled a single-center retrospective cohort of very preterm infants who survived to 36 weeks postmenstrual age, and they applied generalized linear mixed models, a statistical framework well suited to repeated daily measurements nested within individual patients. This approach allowed them to compare day-by-day curves of fluid intake, output, balance, intake-to-output ratio, and weight loss between infants who later developed severe lung disease and those who did not, while adjusting for confounding factors. Their primary exposure was the cumulative fluid output over postnatal days three through seven, a window chosen because the earliest days are dominated by physiological transitions and measurement noise, whereas days three to seven better reflect sustained fluid handling.

Among the 211 infants included, 77, or 36.5 percent, developed moderate-to-severe BPD, a rate consistent with the substantial burden of disease in this gestational age range. When the daily trajectories were compared, one signal stood out: fluid balance over the first week behaved differently in the two groups, with a statistically significant BPD-by-time interaction for daily balance. Daily output, intake, intake-to-output ratio, and percentage weight loss did not differ significantly day by day between the groups. Yet when the researchers turned to cumulative measures across days three to seven, the pattern became sharper and, in one respect, inverted expectations. Every 10 milliliter per kilogram increase in cumulative fluid output over that five-day span was independently associated with higher odds of moderate-to-severe BPD, with an adjusted odds ratio of 1.073 and a 95 percent confidence interval of 1.031 to 1.115.

The crucial methodological move in the study was to separate output from intake. In observational neonatal data, output and intake are tightly coupled, because clinicians often adjust prescribed fluids in response to what the infant is losing, and because balance is by definition the arithmetic difference between the two. A naive analysis of net balance alone can therefore conflate the effects of giving too much fluid with the effects of losing fluid. The authors addressed this by constructing a joint model containing both cumulative output and cumulative intake over days three to seven. In that model, output retained a robust independent association with BPD, while cumulative intake was not statistically significant, with an adjusted odds ratio of 0.961 and a confidence interval of 0.924 to 0.999 that just crossed the null. A reference model using cumulative balance alone showed a reciprocal protective-sounding trend, with an adjusted odds ratio of 0.942, meaning a more positive balance appeared associated with lower odds of severe disease, a finding that is the mirror image of the output result and underscores how strongly the choice of exposure metric shapes conclusions.

That inversion is what makes the study provocative. Conventional neonatal teaching emphasizes cumulative net balance as the key target: a positive balance, meaning more fluid retained than excreted, is traditionally viewed as a risk factor for BPD because it implies pulmonary edema. The new data instead suggest that infants who went on to develop severe lung disease were, if anything, those with higher fluid losses in the first week, even after accounting for how much fluid they received. Several biological interpretations are possible, and the authors are careful to frame their findings as hypothesis generating rather than practice changing. High output could be a marker rather than a cause: infants who are sicker from the start, exposed to more inflammation or receiving nephrotoxic or diuretic medications, may both lose more fluid and be more likely to develop BPD for reasons unrelated to water handling. Alternatively, excessive fluid losses could reflect immature renal concentrating ability, and the resulting dehydration, electrolyte disturbance, and reduced circulating volume might impair perfusion and recovery of the developing lung.

There is also a plausible measurement story. Insensible water losses through the skin and respiratory tract of extremely preterm infants are enormous and difficult to quantify precisely, particularly under radiant warmers or phototherapy, and recorded output in retrospective chart data may miss stool losses or capture errors in weighing diapers. The daily trajectories analysis supports this caution: daily balance, a composite that integrates unmeasured losses implicitly, did show a significant group-by-time difference, while directly recorded daily output did not. Cumulative indices over days three to seven may smooth random error and reveal signal that single-day comparisons miss, but they also amplify any systematic bias in how fluids are charted. The single-center design, while ensuring consistent local practice, limits generalizability to centers with different fluid protocols, humidification strategies, or ventilation practices, and the retrospective nature means confounding by indication can never be fully excluded, even with statistical adjustment.

Statistically, the adjusted odds ratio of roughly 1.07 per 10 milliliters per kilogram is modest in magnitude but clinically meaningful when applied to the large fluid volumes handled over five days: a cumulative output difference of 100 milliliters per kilogram would translate into nearly a doubling of the odds in this model. Still, the confidence interval for intake came tantalizingly close to significance, and the reciprocal balance result suggests that the underlying associations are entangled in ways that only prospective, protocolized data collection can resolve. The study was retrospectively registered in the Chinese Clinical Trial Registry on 10 January 2025, and it was approved by the Institutional Review Board of Shanghai Children’s Medical Center with the consent requirement waived for the use of de-identified retrospective data. The authors declare no competing interests, and the work received no external funding.

For clinicians, the immediate takeaway is not to abandon careful fluid restriction but to pay closer attention to the output side of the ledger. Tracking cumulative output during days three to seven may offer an early window into which infants are at heightened risk of severe BPD, potentially prompting intensified respiratory care, closer renal monitoring, or earlier engagement of families in discussions about long-term follow-up. For researchers, the study identifies a clear agenda: prospective cohorts that simultaneously measure insensible losses, renal biomarkers, biompedance-based estimates of extracellular water, and echocardiographic markers such as hemodynamically significant patent ductus arteriosus, to determine whether high output is a cause, a consequence, or a correlated signature of lung vulnerability. Until such studies arrive, the authors’ message is measured but pointed. The neonatal fluid conversation has been dominated by how much fluid goes in; these findings insist that how much comes out deserves equal scientific scrutiny, and that the humble daily fluid chart, long treated as bookkeeping, may contain underexploited clues to one of prematurity’s most stubborn complications.

Subject of Research: Association of first-week fluid output trajectories with moderate-to-severe bronchopulmonary dysplasia in very preterm infants

Article Title: Association between fluid trajectories in the first postnatal week and moderate-to-severe bronchopulmonary dysplasia in very preterm infants: a retrospective cohort study

Article References: Wang, S., Chen, X., Bei, F., & Bu, J. (2026). Association between fluid trajectories in the first postnatal week and moderate-to-severe bronchopulmonary dysplasia in very preterm infants: a retrospective cohort study. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07728-z

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07728-z

Keywords: bronchopulmonary dysplasia, fluid output, fluid balance, very preterm infant, neonatology, retrospective cohort study, fluid management, prematurity, chronic lung disease, postnatal fluid trajectories, Association, between